Healthcare Finance News January 7, 2022
CMS expects the changes to improve beneficiaries’ experiences with MA and Part D, calling it a “higher standard” of benefits and health equity.
In a move intended to lower out-of-pocket prescription drug costs for beneficiaries, the Centers for Medicare and Medicaid Services issued a proposed rule Thursday updating the Medicare Advantage and Medicare Part D programs, tasking the former with being more transparent in how it spends money on supplemental benefits, and the latter with applying price concessions from drugmakers to the point of sale.
Along with placing a stronger emphasis on those who are dually eligible for Medicare and Medicaid, CMS expects the regulatory changes to improve beneficiaries’ experiences with MA and Part D, calling it a “higher standard”...
Today's Sponsors
Today's Sponsor